C3.ai DTI PI and MIT Professor David Gifford, who proposed a DTI 2020 COVID project to develop new methods for vaccine design using the C3 AI Suite, has published results on a “radically different” COVID vaccine that may work not only against today’s versions of the virus, but future variants as well. 

Drug Discovery & Development reports that “the new, novel vaccine could potentially help fight flu and cancer in the future.”

Read more and also see the research paper and MIT news story linked below.

Boston Globe
Local scientists hope to create the ultimate COVID vaccine

Drug Discovery and Development
This T-cell vaccine could be the future of COVID-19 protection

Frontiers of Immunology
A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

MIT News
Creating a versatile vaccine to take on Covid-19 in its many guises